Table 1.
Dataset | Group | HR | 95%CI | p | |
---|---|---|---|---|---|
TCGA | All | 1.5361 | 1.3669–1.726 | 5.68e-13 | *** |
WHO II | 1.515 | 1.0482–2.189 | 0.0271 | * | |
WHO III | 1.3258 | 1.0868–1.617 | 0.00543 | ** | |
WHO IV | 1.1447 | 0.9519–1.377 | 0.151 | ||
IDH mutant | 1.2393 | 0.9928–1.547 | 0.057922 | ||
IDH wildtype | 1.2441 | 1.0719–1.444 | 0.00406 | ** | |
1p19q codeletion | 1.487 | 0.9152–2.416 | 0.109 | ||
1p19q Non-codeletion | 1.3618 | 1.1942–1.553 | 4.03e-06 | *** | |
CGGA | All | 1.2832 | 1.2107–1.360 | 0 | *** |
WHO II | 1.191 | 1.0026–1.415 | 0.0467 | * | |
WHO III | 1.2822 | 1.1580–1.420 | 1.73e-06 | *** | |
WHO IV | 1.1233 | 1.0368–1.217 | 0.00448 | ** | |
IDH mutant | 1.3049 | 1.1815–1.441 | 1.52e-07 | *** | |
IDH wildtype | 1.1274 | 1.0453–1.216 | 0.00188 | ** | |
1p19q codeletion | 1.26 | 0.9945–1.596 | 0.0556 | ||
1p19q Non-codeletion | 1.2018 | 1.1230–1.286 | 1.07e-07 | *** | |
MGMT methylation | 1.236 | 1.1297–1.352 | 3.78e-06 | *** | |
MGMT Un-methylation | 1.374 | 1.2460–1.514 | 1.79e-10 | *** | |
Primary tumor | 1.329 | 1.2164–1.451 | 2.69e-10 | *** | |
Recurrent tumor | 1.1573 | 1.0720–1.249 | 0.000184 | *** |
HR, hazard ratio; CI, confidence interval;
p < 0.001,
p < 0.01,
p < 0.05.